Cyclobendazole

CAS : 31431-43-3

Ref. 3D-GBA43143

Informations sur le produit

• Nom: Cyclobendazole
• Synonymes: 2-Benzimidazolecarbamic acid, 5-(cyclopropylcarbonyl)-, methyl ester, 5-(Cyclopropylcarbonyl)-2-benzimidazolecarbamic acid methyl ester, 5-Cyclopropylcarbonylcarbendazime, Brn 0755755, Carbamic acid, (5-(cyclopropylcarbonyl)-1H-benzimidazol-2-yl)-, methyl ester, Carbamic acid, N-[6-(cyclopropylcarbonyl)-1H-benzimidazol-2-yl]-, methyl ester, Cc 2481, Ciclobendazol, Ciclobendazol [INN-Spanish], Ciclobendazolum, Ciclobendazolum [INN-Latin], Cyclobendazole [USAN], Haptocil, Methyl 5-(cyclopropylcarbonyl)-2-benzimidazolecarbamate, Nsc 335307, R 17,147, Unii-Jf3Kq40J31, methyl [6-(cyclopropylcarbonyl)-1H-benzimidazol-2-yl]carbamate, Ciclobendazole

Description

Cyclobendazole is a benzimidazole derivative that is used as an anthelmintic drug. It enters the worm's body and prevents the synthesis of ergosterol, which is a component of the cell membrane that protects the cell from harmful substances. Cyclobendazole disrupts the hydrogen bonds by forming new covalent bonds with the DNA bases, leading to programmed death in parasites and worms. This drug has been shown to be effective against inflammatory bowel disease and cancer in clinical studies. Cyclobendazole has also been shown to have anti-inflammatory activity in animal models for inflammatory bowel disease, colitis, and rheumatoid arthritis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 259.26 g/mol
• Formule: C₁₃H₁₃N₃O₃
• Degré de pureté: Min. 95%